New Jersey-based AACE Pharmaceuticals has been slammed in an FDA warning letter citing significant violations by its contract manufacturer Brassica Pharma, including substandard sanitary conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback